New combo pill aims to beat standard blood pressure treatment
NCT ID NCT06643819
First seen Dec 29, 2025 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This study tests a new pill (CKD-202A) that combines two blood pressure medicines (sacubitril and valsartan) against a standard pill (valsartan alone). About 324 adults with high blood pressure will take one of the two pills daily for several weeks. Researchers will measure if the combination pill lowers average blood pressure more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wonju Severance Christian Hospital
RECRUITINGWŏnju, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.